Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
40 /100
MEDIUM RISK
Score updated Aug 28, 2026

DFTX — Definium Therapeutics, Inc. Dilution Risk Tracker

Track DFTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track DFTX — Get alerts when the score changes →

As of August 28, 2026, Definium Therapeutics, Inc. (DFTX) has a DilutionWatch DilutionScore of 40/100, rated MEDIUM dilution risk. Definium Therapeutics, Inc. has a market capitalization of $2.64B, 134.37M shares outstanding, 12 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
0
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for DFTX.
🔔 Track DFTX — Get forecast alerts →

Market Data

Market Cap$2.64B
Shares Outstanding134.37M
Float108.17M
Cash$1.08B
Debt$36.47M
Short InterestN/A

Institutional Holdings

QoQ: ↓ 84.6% shares (2026Q1 vs prior)
12 institutional holders · 9.07M shares
#1 Avoro Capital Advisors LLC 5.00M shares
#2 Candriam S.C.A. 971.2K shares
#3 GOLDMAN SACHS GROUP INC 925.3K shares
+ 9 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest10.74M
Days to Cover6.6
% of Float9.9%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
4 INSIDER TRANSACTION 2026-03-26
4 INSIDER TRANSACTION 2026-03-26
4 INSIDER TRANSACTION 2026-02-05
4 INSIDER TRANSACTION 2026-02-05
Full SEC filing analysis available with free account

Recent News

No recent news

Factual DFTX Dilution Snapshot

Definium Therapeutics, Inc. (DFTX) has a DilutionScore of 40/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track DFTX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking DFTX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for DFTX
DFTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.